Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

TWST vs MTLS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

MTLS Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 5–4 Matrix Metrics)

MTLS Overall Winner 6-Pillar Tally: TWST 3 – 3 MTLS Matrix Metrics: TWST 4 – 5 MTLS

As of Nov 17, 2026, Materialise NV (MTLS) is the stronger overall head-to-head candidate over Twist Bioscience Corporation (TWST) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). TWST carries a Unified Composite Score of 58.9/100 (HOLD) at $112.00 (N/M Forward P/E, -28.8% operating margin), whereas MTLS carries 53.5/100 (HOLD) at $6.28 (N/M Forward P/E, 3.4% operating margin).

  • Composite vs. Pillar Nuance: While TWST currently prints a higher short-term Unified Composite Score (58.9/100 HOLD vs. MTLS 53.5/100 HOLD), MTLS captures the overall institutional head-to-head verdict (5–4 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (3.4% vs. -28.8% operating margin) and revenue trajectory (+2.1% vs. +27.9% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About TWST vs MTLS
TWST NASDAQ
Twist Bioscience Corporation Common Stock
Biological Products, (No Disgnostic Substances)
$112.00
+6.63% 1D
Market Cap $7.4B
TTM Revenue $459M
Forward P/E N/M
Beta / 30D Vol 3.07β · 125% Vol
Unified Composite Score
58.9 / 100 HOLD
Tech 65.0 Fund 62.0 Flow 68.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 39
RSI-14: 39.0 · SMA20: $135.72 · SMA50: $149.49
MTLS NASDAQ Head-to-Head Winner
Materialise NV
Services-Prepackaged Software
$6.28
+1.13% 1D
Market Cap $369.9M
TTM Revenue $605M
Forward P/E N/M
Beta / 30D Vol 1.10β · 88% Vol
Unified Composite Score
53.5 / 100 HOLD
Tech 53.0 Fund 53.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 31
RSI-14: 31.4 · SMA20: $7.28 · SMA50: $7.78

6-Pillar Scorecard Institutional Category Breakdown (TWST 3 – 3 MTLS)

Columns: Metric · TWST · MTLS
1. Valuation Multiples MTLS
Forward P/E N/M N/M
Trailing P/E N/M 25.0x
PEG Ratio N/M 1.26x
EV / Revenue 16.1x 0.6x
2. Growth & Scale TWST
Revenue Growth (YoY) +27.9% +2.1%
Earnings Growth (YoY) +0.0% -33.3%
TTM Revenue (USD) $459M $605M
Market Cap $7.4B $369.9M
3. Profitability & Quality MTLS
Gross Margin 52.4% 57.4%
Operating Margin -28.8% 3.4%
Net Profit Margin -28.3% 4.6%
Return on Equity (ROE) -19.1% 5.0%
4. Balance Sheet & Cash Flow MTLS
Cash Generation (TTM) -$107M EBITDA $55M EBITDA
Cash Flow Margin -23.4% EBITDA Mgn 9.1% EBITDA Mgn
Net Cash / Leverage $13.61 Book/Sh · -19.1% ROE $4.97 Book/Sh · 5.0% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning TWST
Options Structure Phase CONSOLIDATION UNCLASSIFIED
Current IV / %ile 100.1% (19th %ile) N/A (N/A)
Put/Call OI Skew 1.31x (Put-Skewed) Thin ADR Chain
OBV Trend / Tech Phase DISTRIBUTION · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat TWST
OpEx & R&D Intensity 81.2% of Rev ($373M) 54.0% of Rev ($327M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Software - Application Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: TWST (4) vs MTLS (5)
Institutional Metric TWST MTLS Criterion Row Edge
Market Capitalization
Scale
$7.4B $369.9M Larger Scale TWST
Trailing P/E Ratio
Valuation
N/M 25.0x Lower Multiple MTLS
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+27.9% +2.1% Higher Growth TWST
Operating Margin (TTM)
Profitability
-28.8% 3.4% Higher Margin MTLS
Net Profit Margin
Profitability
-28.3% 4.6% Higher Margin MTLS
Return on Equity (ROE)
Capital Efficiency
-19.1% 5.0% Higher ROE MTLS
52-Week Range Position
Momentum
45% ($23–$220) 37% ($5–$9) Stronger Trend TWST
Beta / 30D Volatility
Risk Regime
3.07β · 125% Vol 1.10β · 88% Vol Lower Realized Risk MTLS
Unified Institutional Score
Composite Signal
58.9 / 100 (HOLD) 53.5 / 100 (HOLD) Higher Composite TWST
Trailing 12M Revenue (USD)
Operating Scale
$459M $605M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
52.4% 57.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 16.1x EV/Rev 1.26x PEG · 0.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$107M EBITDA ($13.61 Book/Sh · -19.1% ROE) $55M EBITDA ($4.97 Book/Sh · 5.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon TWST +2.65 pp
TWST: -19.87% · MTLS: -22.52%
3M Horizon MTLS +16.93 pp
TWST: -21.34% · MTLS: -4.41%
6M Horizon TWST +113.31 pp
TWST: +126.26% · MTLS: +12.95%
1Y Horizon TWST +312.33 pp
TWST: +316.82% · MTLS: +4.49%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TWST vs MTLS. Trailing 12-month operating profitability (TWST -28.8% vs MTLS 3.4%) and valuation multiples (TWST N/M vs MTLS N/M Forward P/E) are benchmarked directly in Pillar 4 below.

TWST ADR TTM Benchmark FX-Normalized USD
TTM Revenue$459M
Gross Margin52.4%
Op. Margin-28.8%
ROE / Fwd P/E-19.1% · N/M
MTLS ADR TTM Benchmark FX-Normalized USD
TTM Revenue$605M
Gross Margin57.4%
Op. Margin3.4%
ROE / Fwd P/E5.0% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
TWST CONSOLIDATION
70d in phase · OBV DISTRIBUTION
Current IV 100.1%
IV Percentile 19th %ile
Put/Call OI Skew 1.31x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact TWST Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
MTLS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew Thin ADR Chain
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact MTLS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $105.82 · IV 95.9%

TWST Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($10,582)

Compare $10,582 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 95.9% ATM IV.

5-DAY BULLISH SWING Liq C

Dec 18 $115 / $130 Bull Call Spread

Buy 1x $115C · Sell 1x $130C · 31d

Net Entry $130 Debit
T+5d @ +5% Move +$81 (+62%)
Max Risk / Buffer $130 Capped
5d Edge & Liquidity 1.6x R:R · Liq C
Simulate 5-Day Payoff →
ASYMMETRIC 3-LEG STRUCTURE Liq C

Dec 18 $90P / $115-$130C Seagull

Sell 1x $90P · Buy 1x $115/$130C · 31d

Net Entry $390 Credit
T+5d @ +5% Move +$281 (+27.3% RoM)
Max Risk / Buffer -14.9% Put Cushion ($1,030 Mgn)
5d Edge & Liquidity 1.7x R:R · Liq C
Simulate 5-Day Payoff →
5-DAY DOWNSIDE SPREAD Liq B

Dec 18 $110 / $90 Bear Put Spread

Buy 1x $110P · Sell 1x $90P · 31d

Net Entry $940 Debit
T+5d @ -5% Drop +$129 (+14%)
Max Risk / Buffer $940 Capped
5d Edge & Liquidity 0.7x R:R · Liq B
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
TWST Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $7.4B market capitalization and -28.8% operating margin.
OpEx & R&D Reinvestment 81.2% of Rev ($373M)
90D Engineering Disclosures 0 Published · Spatial Genomics
MTLS Moat Profile Cyclical / Execution-Driven Positioning
Software - Application Operator
Competes within the Software - Application value chain with $369.9M market capitalization and 3.4% operating margin.
OpEx & R&D Reinvestment 54.0% of Rev ($327M)
90D Engineering Disclosures 0 Published

Investor FAQ TWST vs MTLS Key Questions & Quantitative Answers

As of Nov 17, 2026, Materialise NV (MTLS) is the stronger overall head-to-head candidate over Twist Bioscience Corporation (TWST) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). TWST carries a Unified Composite Score of 58.9/100 (HOLD) at $112.00 (N/M Forward P/E, -28.8% operating margin), whereas MTLS carries 53.5/100 (HOLD) at $6.28 (N/M Forward P/E, 3.4% operating margin). Composite vs. Pillar Nuance: While TWST currently prints a higher short-term Unified Composite Score (58.9/100 HOLD vs. MTLS 53.5/100 HOLD), MTLS captures the overall institutional head-to-head verdict (5–4 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (3.4% vs. -28.8% operating margin) and revenue trajectory (+2.1% vs. +27.9% YoY).

TWST leads the Growth & Scale pillar: TWST posts +27.9% YoY revenue growth and +0.0% YoY earnings growth on $459M TTM revenue (52.4% gross margin, -28.8% operating margin), compared with MTLS at +2.1% YoY revenue growth and -33.3% YoY earnings growth on $605M TTM revenue (57.4% gross margin, 3.4% operating margin). On trailing 12-month operating scale, TWST generates $459M in USD-normalized revenue versus $605M for MTLS. In operating R&D and SG&A reinvestment, TWST deploys 81.2% of Rev ($373M) (0 90-day corporate R&D disclosures) versus 54.0% of Rev ($327M) (0 disclosures) for MTLS.

MTLS screens cheaper on headline valuation multiples. TWST trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 16.1x EV/Revenue (-23.4% EBITDA margin), whereas MTLS trades at N/M Forward P/E, 25.0x Trailing P/E, 1.26x PEG, and 0.6x EV/Revenue (9.1% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against TWST (-19.1% ROE) versus MTLS (5.0% ROE) capital efficiency.

In options market volatility and institutional positioning, TWST carries 100.1% implied volatility (19th %ile, Compressed (<25th %ile)), a 1.31x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (3.07β · 125% Vol realized risk). By comparison, MTLS carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.10β · 88% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.